Can Olaparib Tablets Shrink Tumors?

Yes, olaparib can reduce tumors, particularly in some cancers consisting of BRCA1 or BRCA2 mutations and most cancers of the ovaries, breast, prostate and pancreas. Olaparib is a PARP inhibitor that works by helping cancer cells block DNA restore, preventing them from dropping their viability or growing. Clinical studies have proven that olaparib can significantly lessen tumor length and improve development-loose survival in eligible patients. Always discuss with your health care provider to determine if olaparib is appropriate to your treatment routine to determine efficiency blessings and aspect consequences.